Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer

NCT00584012 is registered in ClinicalTrials.gov with Susan L Roeder as lead sponsor.

NCT NCT00584012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00584012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer
Lead sponsor
Susan L Roeder
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2004
Completion date
April 30, 2009
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

any cancer, breast cancer